Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
39 studies found for:    "familial male-limited precocious puberty" OR "Puberty, Precocious"
Show Display Options
Rank Status Study
1 Active, not recruiting
Has Results
Pediatrics Testotoxicosis Study [Bicalutamide Anastrozole Treatment for Testotoxicosis]
Condition: Puberty, Precocious
Interventions: Drug: Bicalutamide;   Drug: Anastrozole
2 Completed
Has Results
Study of Lupron Depot In The Treatment of Central Precocious Puberty
Condition: Puberty, Precocious
Intervention: Drug: Lupron (leuprolide acetate)
3 Completed
Has Results
A Study of Leuprolide 11.25 mg and 30 mg Administered Every 3 Months to Treat Central Precocious Puberty
Condition: Puberty, Precocious
Interventions: Drug: Leuprolide acetate 11.25 mg;   Drug: Leuprolide acetate 30 mg
4 Recruiting Effect of a GnRH Injection on Ghrelin Concentrations in Girls With Suspected Premature Puberty
Condition: Puberty, Precocious
Interventions: Drug: Gonadotropin releasing hormone (GnRH);   Drug: Sodium Chloride
5 Recruiting A Study to Assess the Safety and Efficacy of Leuprorelin in Central Precocious Puberty in Chinese Patients
Condition: Puberty, Precocious
Intervention: Drug: Leuprorelin
6 Completed Psychosocial Impact of Early Puberty in Girls Aged 6 to 8 Years
Condition: Early Puberty
Intervention:
7 Unknown  Analysis of Genetic and Environmental Parameters Influencing Growth Rate of Precocious Puberty Children
Condition: Central Precocious Puberty
Interventions: Drug: Triptorelin (GnRH agonists);   Drug: Leuprolide (GnRH agonists)
8 Completed Treatment of Boys With Precocious Puberty
Condition: Precocious Puberty
Interventions: Drug: Spironolactone;   Drug: Testolactone;   Drug: Deslorelin
9 Unknown  Markers of Pubertal Suppression During Therapy for Precocious Puberty
Condition: Central Precocious Puberty
Intervention:
10 Completed Histrelin Subcutaneous Implant in Children With Central Precocious Puberty
Condition: Central Precocious Puberty
Intervention: Drug: Histrelin Subcutaneous Implant
11 Unknown  First-Voided Urinary LH vs. GnRH-stimulation in Differentiating Slowly- From Rapidly Progressive-Precocious Puberty
Condition: Precocious Puberty, Gonadotropin-dependent
Interventions: Other: Measurement of LH in first-voided urine;   Other: collection of first-voided urine sample for LH level
12 Recruiting Clinical Trial of Experienced Chinese Herbal Formulas on Different Types of Precocious Puberty
Condition: Precocious Puberty
Interventions: Drug: ziyinxiehuo Granules;   Drug: zishenqinggan Granules
13 Completed
Has Results
Efficacy and Safety Study of Pamoate of Triptorelin in Children With Precocious Puberty
Condition: Precocious Puberty
Intervention: Drug: Triptorelin pamoate 11.25mg (Decapeptyl® SR)
14 Completed Effects of Triptorelin Pamoate in Children With Precocious Puberty - Follow up Study
Condition: Precocious Puberty
Intervention: Drug: Triptorelin (I.N.N.)
15 Completed Study of Comprehensive Diagnosis and Treatment for Children Precocious Puberty
Condition: Central Precocious Puberty
Interventions: Drug: Triptorlin or Leuprorelin;   Drug: Zhibo dihuang pills;   Drug: Dabu ying pills
16 Enrolling by invitation Long-term Outcome of GnRH Analogues Treatment of Children With Idiopathic Central Precocious Puberty
Conditions: Puberty, Precocious;   Adiposity
Intervention: Other: GnRHas
17 Recruiting Analysis of Body Mass Index in Central Precocious Puberty Patients Treated With Leuprolide Acetate
Condition: Precocious Puberty, Central
Intervention: Drug: Leuprolide
18 Completed
Has Results
Efficacy, Safety, and Pharmacokinetics (PK) of Triptorelin 6-month Formulation in Patients With Central Precocious Puberty
Condition: Central Precocious Puberty
Intervention: Drug: Triptorelin
19 Recruiting Pharmacokinetic Study of Leuprolide Acetate Injectable Suspension in the Treatment of Central Precocious Puberty
Condition: Precocious Puberty, Central
Intervention: Drug: Leuprolide Acetate 45 mg
20 Completed The Clinical Trial to Evaluate the Efficacy and Safety of Luphere Depot Inj. 3.75mg(Leuprolide Acetate 3.75mg) in Patients With Precocious Puberty
Condition: Central Precocious Puberty
Intervention: Drug: Luphere depot 3.75mg(Leuprolide acetate 3.75mg)

   Previous Page Studies Shown (1-20) Next Page (21-39) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.